View Older Stories View More Recent Stories

Aug 19, 2022 04:18PM Form SC 13D/A TELA Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 18, 2022 04:39PM Form SC 13D/A Terns Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Aug 17, 2022 04:32PM Form 4 Xtant Medical Holdings, For: Aug 15 Filed by: ORBIMED ADVISORS LLC
Aug 15, 2022 04:32PM Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
Aug 12, 2022 02:30PM Form SC 13D/A Verona Pharma plc Filed by: ORBIMED ADVISORS LLC
Aug 10, 2022 04:23PM Form 4 SpringWorks Therapeutics For: Aug 08 Filed by: ORBIMED ADVISORS LLC
Aug 8, 2022 04:27PM Form SC 13D/A Arcutis Biotherapeutics, Filed by: ORBIMED ADVISORS LLC
Aug 1, 2022 04:05PM TransMedics Reports Second Quarter 2022 Financial Results
Jul 26, 2022 10:00AM Scribe Therapeutics Announces Expansion of San Francisco Bay Area Headquarters, 3 Key Senior Hires
Jul 15, 2022 10:00AM Scribe Therapeutics to Participate in SVB Securities Biopharma Private Company Connect
Jul 11, 2022 08:14AM Enavate Sciences Appoints Industry Veteran Robert Glassman as Executive Vice President, Search & Evaluation
Jul 5, 2022 04:31PM Form SC 13D/A 89bio, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 28, 2022 04:23PM Form SC 13D/A Arcutis Biotherapeutics, Filed by: ORBIMED ADVISORS LLC
Jun 23, 2022 09:15AM Radius Health (RDUS) Acquired by Gurnet Point Capital and Patient Square Capital for $10/sh Plus CVR of $1/sh
Jun 23, 2022 09:15AM Radius Health Announces Agreement to be Acquired by Gurnet Point Capital and Patient Square Capital
Jun 23, 2022 09:15AM Radius Health Announces Agreement to be Acquired by Gurnet Point Capital and Patient Square Capital
Jun 22, 2022 06:00AM Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer
May 25, 2022 03:00PM Chau Khuong Joins Catalio Capital Management as General Partner
May 16, 2022 04:27PM Form 13F-HR ORBIMED ADVISORS LLC For: Mar 31
May 5, 2022 05:33PM Form 4 Passage BIO, Inc. For: May 03 Filed by: ORBIMED ADVISORS LLC
May 5, 2022 05:21PM Form 4/A Passage BIO, Inc. For: Jan 20 Filed by: ORBIMED ADVISORS LLC
May 5, 2022 05:14PM Form SC 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
May 2, 2022 10:00AM Scribe Therapeutics Expands Collaboration With Biogen to Second Target
Apr 29, 2022 06:30PM SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-F
Apr 8, 2022 05:21PM Form SC 13D/A Arcutis Biotherapeutics, Filed by: ORBIMED ADVISORS LLC
Apr 1, 2022 05:07PM Form SC 13D/A PMV Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Apr 1, 2022 10:00AM Scribe Therapeutics to Participate in Upcoming Goldman Sachs The New Guard: Privates Leading the Disruption in Healthcare Investor Conference
Mar 17, 2022 07:30AM Gennao Bio Strengthens Board of Directors with Appointments of Peter Thompson, M.D., and Bradley Campbell
Mar 15, 2022 04:31PM Form SC 13D/A Sierra Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Mar 9, 2022 10:00AM Scribe Therapeutics Appoints David Parrot as Chief Financial Officer and George Manning as Controller
Mar 7, 2022 07:00AM Brookline Capital Markets Announces Promotions
Feb 15, 2022 09:43PM Form 4 Kinnate Biopharma Inc. For: Feb 11 Filed by: ORBIMED ADVISORS LLC
Feb 14, 2022 04:42PM Form 13F-HR ORBIMED ADVISORS LLC For: Dec 31
Feb 11, 2022 05:38PM Form SC 13G/A Xenon Pharmaceuticals Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:19PM Form SC 13G/A X4 Pharmaceuticals, Inc Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:17PM Form SC 13G/A Verrica Pharmaceuticals Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:15PM Form SC 13G VectivBio Holding AG Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:10PM Form SC 13G/A VistaGen Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:07PM Form SC 13G/A Harpoon Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:04PM Form SC 13G/A Strongbridge Biopharma Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:03PM Form SC 13G/A Pandion Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:03PM Form SC 13G Sonendo, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:01PM Form SC 13G/A NeuroPace Inc Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:59PM Form SC 13G/A Theravance Biopharma, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:55PM Form SC 13G/A OTONOMY, INC. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:55PM Form SC 13G Protara Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:51PM Form SC 13G RxSight, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:48PM Form SC 13G/A Mereo Biopharma Group Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:48PM Form SC 13G/A MeiraGTx Holdings plc Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:47PM Form SC 13G/A Crinetics Pharmaceutical Filed by: ORBIMED ADVISORS LLC
View More Recent Stories View Older Stories